Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic

RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi...

Full description

Saved in:
Bibliographic Details
Published inCancer biology & therapy Vol. 7; no. 1; pp. 145 - 151
Main Authors Yang, Nan, Zhu, Xiangying, Chen, Lishan, Li, Shenghua, Ren, Daming
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.01.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi in vitro and in vivo. Upon oral administration, S.typhimurium carrying shRNA-expressing vectors targeting bcl2 induced significant gene silencing in murine melanoma cells that led to a remarkably delayed tumor growth and prolonged survival in the mouse model. These results suggest that bacteria mediated RNAi may be a new potent approach to the treatment of cancers.
AbstractList RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi in vitro and in vivo. Upon oral administration, S.typhimurium carrying shRNA-expressing vectors targeting bcl2 induced significant gene silencing in murine melanoma cells that led to a remarkably delayed tumor growth and prolonged survival in the mouse model. These results suggest that bacteria mediated RNAi may be a new potent approach to the treatment of cancers.
Author Chen, Lishan
Ren, Daming
Li, Shenghua
Yang, Nan
Zhu, Xiangying
Author_xml – sequence: 1
  givenname: Nan
  surname: Yang
  fullname: Yang, Nan
– sequence: 2
  givenname: Xiangying
  surname: Zhu
  fullname: Zhu, Xiangying
– sequence: 3
  givenname: Lishan
  surname: Chen
  fullname: Chen, Lishan
– sequence: 4
  givenname: Shenghua
  surname: Li
  fullname: Li, Shenghua
– sequence: 5
  givenname: Daming
  surname: Ren
  fullname: Ren, Daming
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18059172$$D View this record in MEDLINE/PubMed
BookMark eNptkE1v1DAQhi1URD_gxhnlxIkE24nj5FhVtEWqqNTC2Zo4E9ZVEoexQ9l_j6Nd4IJkaazRM--MnnN2MvsZGXsreFGJWny0XSx0IQolWvWCnQmlVN4oXZ9s_7LJK17pU3YewhPnUsu6fcVORcNVK7Q8Y0_3BGMG_eRmFyJBdH7O_JBBjDivELHPHoss7pedm1Zy65RZINq7-XsWdg9fLnP8tRCGsDV-oo2eQgbpJWy2SFncIcGCa3T2NXs5wBjwzbFesG_Xn75e3eZ39zefry7vcltVTcyHpuVtqXQDSkEpm0ZYC6ouu6HtlKhqkFzzGq0GLluusOusBAlKl9I2VSvLC_b-kLuQ_7FiiGZyweI4wox-DaZuRSV1qRP44QBa8iEQDmYhNwHtjeBmc2uSW6ONMJvbhL875q7dhP0_-CgzAfwApE09hs75YB0mDX_RLQ8ouRjxT6Y-jLh58DTBs6exNxH2o6eBkkIXTPnfa34DDIWc8A
CitedBy_id crossref_primary_10_1016_j_addr_2016_09_007
crossref_primary_10_1016_j_intimp_2020_107052
crossref_primary_10_1007_s00109_010_0636_z
crossref_primary_10_1016_j_bmhimx_2015_02_005
crossref_primary_10_3724_abbs_2023007
crossref_primary_10_1007_s13139_016_0415_z
crossref_primary_10_1016_j_biopha_2021_112443
crossref_primary_10_1038_s41571_024_00908_9
crossref_primary_10_2478_s11658_009_0032_2
crossref_primary_10_1016_j_molmed_2012_05_006
crossref_primary_10_1097_CJI_0b013e3181cf23a6
crossref_primary_10_1073_pnas_1201620109
crossref_primary_10_1016_j_heliyon_2023_e17148
crossref_primary_10_1039_D1BM00634G
crossref_primary_10_1073_pnas_0912813107
crossref_primary_10_3858_emm_2011_43_2_008
crossref_primary_10_1016_j_canlet_2019_01_037
crossref_primary_10_3389_fimmu_2023_1277677
crossref_primary_10_1080_1061186X_2020_1737087
crossref_primary_10_1111_1751_7915_13523
crossref_primary_10_3390_biomedicines9111566
crossref_primary_10_1049_enb2_12032
crossref_primary_10_1038_nrc2934
crossref_primary_10_1038_gt_2010_112
crossref_primary_10_1038_mt_2013_37
crossref_primary_10_3389_fcimb_2023_1293351
crossref_primary_10_1016_j_intimp_2024_111935
crossref_primary_10_1371_journal_pone_0129276
crossref_primary_10_4161_bbug_1_6_13146
crossref_primary_10_1155_2016_8451728
crossref_primary_10_1016_j_tibtech_2010_07_009
crossref_primary_10_1039_c1mb05016h
crossref_primary_10_1002_jso_24644
crossref_primary_10_1016_j_addr_2022_114366
crossref_primary_10_1371_journal_pone_0065268
crossref_primary_10_3390_pharmaceutics14040784
crossref_primary_10_1089_dna_2010_1118
crossref_primary_10_61186_ijbc_15_4_178
crossref_primary_10_3390_cancers11091314
crossref_primary_10_1016_j_actbio_2021_02_006
crossref_primary_10_3390_cancers11101592
crossref_primary_10_1073_pnas_1014975108
crossref_primary_10_3390_pharmaceutics14102100
crossref_primary_10_1016_j_cyto_2016_01_002
crossref_primary_10_1016_j_copbio_2011_03_009
crossref_primary_10_1016_j_cbpa_2012_04_009
crossref_primary_10_3389_fimmu_2021_615930
crossref_primary_10_1038_gt_2010_176
crossref_primary_10_1007_s40588_019_00132_5
crossref_primary_10_1038_s41568_018_0070_z
crossref_primary_10_4155_tde_11_22
crossref_primary_10_3390_cancers14174224
crossref_primary_10_3390_vaccines3040940
ContentType Journal Article
Copyright Copyright © 2008 Landes Bioscience 2008
Copyright_xml – notice: Copyright © 2008 Landes Bioscience 2008
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4161/cbt.7.1.5195
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1555-8576
EndPage 151
ExternalDocumentID 10_4161_cbt_7_1_5195
18059172
10905195
Genre Research Paper
Journal Article
GroupedDBID ---
00X
0VX
0YH
29B
30N
53G
5GY
6J9
AAAVI
ABCCY
ABEIZ
ABFIM
ACENM
ACGFO
ACGFS
ACTIO
ADBBV
ADCVX
AECIN
AEGYZ
AEISY
AENEX
AEXWM
AFPKN
AGYJP
AIJEM
AIRBT
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
AQRUH
AVBZW
BABNJ
BAWUL
BLEHA
C1A
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
F5P
HYE
IH2
KSSTO
KYCEM
M4Z
O9-
OK1
P2P
P6G
RPM
SJN
TDBHL
TFL
TFT
TFW
TR2
TTHFI
-
0R
ABJVF
AGCAB
AIRXU
AWQZV
H13
RNANH
ROSJB
RTWRZ
TQWBC
4.4
ACKZS
ADFZZ
AURDB
BFWEY
CGR
CUY
CVF
CWRZV
ECM
EIF
EJD
EMOBN
GROUPED_DOAJ
IPNFZ
LJTGL
NPM
PCLFJ
RIG
UDS
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c448t-f89093578a55a32881cca563bf9b5146a20706ec7a02905ebbc2a2a5732c84923
ISSN 1538-4047
IngestDate Fri Oct 25 05:44:02 EDT 2024
Fri Aug 23 03:08:01 EDT 2024
Sat Sep 28 08:34:00 EDT 2024
Fri Jan 15 03:37:28 EST 2021
Sun Aug 04 07:04:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c448t-f89093578a55a32881cca563bf9b5146a20706ec7a02905ebbc2a2a5732c84923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18059172
PQID 69142737
PQPubID 23479
PageCount 7
ParticipantIDs crossref_primary_10_4161_cbt_7_1_5195
proquest_miscellaneous_69142737
landesbioscience_primary_cbt_article_5195
informaworld_taylorfrancis_310_4161_cbt_7_1_5195
pubmed_primary_18059172
PublicationCentury 2000
PublicationDate 1/1/2008
2008/01/01
2008-Jan
2008-01-00
20080101
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – month: 01
  year: 2008
  text: 1/1/2008
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer biology & therapy
PublicationTitleAlternate Cancer Biol Ther
PublicationYear 2008
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References 18347415 - Cancer Biol Ther. 2008 Jan;7(1):151-2
References_xml
SSID ssj0027269
Score 2.1489034
Snippet RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene...
SourceID proquest
crossref
pubmed
landesbioscience
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 145
SubjectTerms Administration, Oral
Animals
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Down-Regulation
Gene Transfer Techniques
Genes, bcl-2
Genetic Vectors
Landes
Mice
Neoplasms - therapy
Organogenesis
Polymerase Chain Reaction
Proteins
RNA Interference
RNA, Small Interfering - genetics
Salmonella typhimurium - genetics
Title Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic
URI https://www.tandfonline.com/doi/abs/10.4161/cbt.7.1.5195
http://www.landesbioscience.com/journals/cbt/article/5195/
https://www.ncbi.nlm.nih.gov/pubmed/18059172
https://search.proquest.com/docview/69142737
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgSAgOjG_KBvgABw7J4iSOk-M0DU0IisQ2qXCx7NRZh9R2ahME_PW8ZztLUjYJkKqosp26yu_nl_fs90HI6yIyTBllApZFVZBqkQbKJEXAp5mKTV6WqbZevuPs6DR9P-GTzlfVRpfUOix_XRlX8j-oQhvgilGy_4Ds5Y9CA3wHfOEKCMP1rzD-hNH1apD-1p7r16AIN8rqkiFuss7O583qvJljHuqVjWtazz6P9wPzw7nBQsN34-ruqDWGSyIVrPdhG5vV12EPXG-bvgm5Uw9zE3zxm9DjjnpfZw22TICNZz_b16V1K3By7wNWge7cg6yPwTH0nc0aNdiZyHs7E8ZLU86DnLsCL624FX-wyolO5tJKbop0NMAAh1LXoQhZiMlw-sMAkIu5hZfloCkyVwdoI4V223WT3IpBHqEgTKJxZ5fHWeFiInCyvf5UmFPW3zxQXAZpbe-SbfRCxQM9n4DUXG-vWL3l5D655w0Ouu_Y84DcMIuH5PZH71LxiHxDEtEhieiyoh2J6HFIeySiLYnoJomoJxFV8KGORLRHosfk9N3hycFR4AtwBCVY7XVQ5QWek4tcca6SOM8ZrHeeJboqNCjasJrhhZGZUqgoLiJutC5jFSsukrjMMfPfE7K1WC7MM0KZqHiaTJUpoyQFHTUvp1woFVdaC5AibETetE9XXrg8KxLsUwREAiBSSCYRkBGJ-o9e1nZfq3JFaGRy9S1vN-G5nALH-eXrx75qcZMgZ_HwTC3MslnLrGApqPpiRJ46OLu_6Qny_NqeHXKnWx-7ZKteNeYF6LK1fmmZ-Bsf0KT1
link.rule.ids 315,783,787,27936,27937,60214,61003
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1Bkfg4tAUKbCmtD3DgkDRO4jg5VlWrhbZbCVqp4mLZXkdtUbNVNkHAr-9MnKW7BQ4g5ZTYiu2Zsd94xs8Ab4vIce20C3gWlUFqZBpolxSBGGc6drm1qemyfEfZ8DT9eCbO5q76orRK8qFLTxTRzdVk3LQZTRZOeHzbmiaUIQ-JGeU-PMiI94tOb0SjW18r7m6z6-w5jVLpc95_q72wGi1wlT6BFUotpChNzyrp_g5Cu8VofwW-zLrhc1C-hm1jQvvzDsPjf_VzFZZ7iMp2vE49hXuuegYPj_og_HO4PK7xs15g3WWTkhFTZ9Uidh2zzyFrflyfX1y19UV7xayuazpOxabnn0Y7gfvus2_xxbcuaDBlGh8sht2v2dyRsDU43d872R0G_ZUNgUU_rwnKvKDIqsy1EDqJ85yjhogsMWVhEJqh_HGKyZyVOoqLSDhjbKxjLWQS25y44l7AUjWp3CtgXJYiTcba2ShBJ5Tndiyk1nFpjES94wN4NxOduvbMHAo9Gho4hQOnpOKKBm4A0bxcVdPthJT-2hKV_LnK-7uy__ULKtcbdV92a6YUCi2Twi26cpN2qrKCpwgO5QBeel25bWaOoBaR4_q_N20LHg1Pjg7V4YfRwWt47LNXaENoA5aaunVvECI1ZrMzhhvothEP
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVwoLxZXvUBDhyS2kkcO8cKWJXXgoBK5WTZjq0W1OwqmyDg1zOOs7Rb4ABSTomt2J4Z-xvP-DPAo4o6pp12CSupTwojikS7vEp4XerMSWsLM2T5zsr9g-LlIT_cALk6CxPSKoMP7SNRxDBXB-Ne1D4YeIDju9Z0qUhZGohRLsBFBAA0aHhOZ6euVjZcZjeYc0ELEVPef6u9thitUZVehu2QWRiCNCOppPs7Bh3Wouk2fFr1IqagfEn7zqT2xzmCx__p5lW4MgJUshc16hpsuOY6bL0ZQ_A34PPbFj_rNc5dMvck8HQ2PSLXmnxISfd9cXR80rfH_Qmxum3DYSqyPHo_20vct5h7iy--DiGDJdH4YDHsfUvOHAi7CQfT5x-f7ifjhQ2JRS-vS7ysQlxVSM25zjMpGeoHL3PjK4PADKWPE0zprNA0qyh3xthMZ5qLPLMyMMXdgs1m3rg7QJjwvMhr7SzN0QVl0tZcaJ15YwRqHZvA45Xk1CLycij0Z8LAKRw4JRRTYeAmQM-KVXXDPoiPl5ao_M9VnpwX_a9fhHKjSY9ld1Y6odAuQ7BFN27eL1VZsQKhoZjA7agqp82UCGkRN97996btwNa7Z1P1-sXs1T24FFNXwm7Qfdjs2t49QHzUmYeDKfwEuDkPvA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+administration+of+attenuated+S.+typhimurium+carrying+shRNA-expressing+vectors+as+a+cancer+therapeutic&rft.jtitle=Cancer+biology+%26+therapy&rft.au=Yang%2C+Nan&rft.au=Zhu%2C+Xiangying&rft.au=Chen%2C+Lishan&rft.au=Li%2C+Shenghua&rft.date=2008-01-01&rft.eissn=1555-8576&rft.volume=7&rft.issue=1&rft.spage=145&rft_id=info:doi/10.4161%2Fcbt.7.1.5195&rft_id=info%3Apmid%2F18059172&rft.externalDocID=18059172
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-4047&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-4047&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-4047&client=summon